We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging CVS Health (CVS) This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has CVS Health (CVS - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
CVS Health is a member of our Medical group, which includes 956 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. CVS Health is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for CVS' full-year earnings has moved 4% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that CVS has returned about 79.7% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 0.5% on average. This shows that CVS Health is outperforming its peers so far this year.
Alignment Healthcare (ALHC - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 53.9%.
In Alignment Healthcare's case, the consensus EPS estimate for the current year increased 46.4% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, CVS Health belongs to the Medical Services industry, a group that includes 64 individual stocks and currently sits at #96 in the Zacks Industry Rank. This group has gained an average of 0.5% so far this year, so CVS is performing better in this area. Alignment Healthcare is also part of the same industry.
Investors with an interest in Medical stocks should continue to track CVS Health and Alignment Healthcare. These stocks will be looking to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging CVS Health (CVS) This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has CVS Health (CVS - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
CVS Health is a member of our Medical group, which includes 956 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. CVS Health is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for CVS' full-year earnings has moved 4% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that CVS has returned about 79.7% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 0.5% on average. This shows that CVS Health is outperforming its peers so far this year.
Alignment Healthcare (ALHC - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 53.9%.
In Alignment Healthcare's case, the consensus EPS estimate for the current year increased 46.4% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, CVS Health belongs to the Medical Services industry, a group that includes 64 individual stocks and currently sits at #96 in the Zacks Industry Rank. This group has gained an average of 0.5% so far this year, so CVS is performing better in this area. Alignment Healthcare is also part of the same industry.
Investors with an interest in Medical stocks should continue to track CVS Health and Alignment Healthcare. These stocks will be looking to continue their solid performance.